Page 58 - JCTR-11-4
P. 58

Journal of Clinical and
            Translational Research                                             AR-TAVR coaxiality assessment using 3DP




                                        transapical TAVR. In the future, randomized clinical trials will be needed to evaluate
                                        the efficacy and accuracy of pre-procedural 3DP simulations and the coaxiality index
                                        in treating patients with pure AR undergoing transapical TAVR.


                                        Keywords: Aortic regurgitation; Transcatheter aortic valve replacement; Three-dimensional
                                        printing; Coaxiality; Clinical outcome



            1. Introduction                                    2. Materials and methods

            Aortic regurgitation (AR) is the fourth most common   2.1. Study design and population
            type of valvular heart disease globally,  with a prevalence   A total of 694 high-risk patients with AR from six high-volume
                                           1
            of 4.9%.  The indications for transcatheter aortic valve   centers (Xijing Hospital; Beijing Fuwai Hospital; West China
                   2
            replacement  (TAVR)  continue  to  expand,  and  its  safety   Hospital  Affiliated  with  Sichuan  University;  Zhongshan
            and efficacy have been demonstrated even in patients with   Hospital Affiliated with Fudan University; Anzhen Hospital
                                           3,4
            low-surgical risk aortic stenosis  (AS).  However, TAVR   Affiliated to Capital Medical University; and Guangdong
            presents unique anatomical challenges in patients with AR,   Provincial People’s Hospital) were enrolled from January
            including a larger annulus, lack of calcification, and dilation   2018 to March 2020. The inclusion criteria included (i)
            of the ascending aorta.  As a result, off-label implantation   age ≥60 years; (ii) New York Heart Association functional
                              5
            using a conventional transcatheter heart valve (THV) is   class ≥II; (iii) ≥Moderate AR diagnosed by transthoracic
            more difficult, leading to a higher incidence of paravalvular   echocardiography; and (iv) European System for Cardiac
            leakage (PVL), THV displacement, and conduction block. 6  Operative Risk  Evaluation  score II  >12%  or  Society  of
              In its early stages, the J-Valve (Jiecheng Medical Co.,   Thoracic Surgeons (STS) score >8%. The exclusion criteria
            LTD., China) was developed specifically for the treatment   were (i) <Moderate AR; (ii) myocardial infarction within the
            of pure AR and has demonstrated therapeutic effectiveness   past month; (iii) history of endocarditis; (iv) hypertrophic
            in China.  The distinctive design features of the THV   cardiomyopathy; and (v) transient ischemic attack/stroke
                    7
            include three U-shaped positioning keys and a movable   within the past 6 months. In addition, patients unsuitable
            connection between the keys and the THV.  The inward   for transapical TAVR were excluded from the study. Of
                                                7
            force of the positioning keys and the outward radial force   the patients enrolled initially, 82 were excluded. The 3DP
            of the THV clamp the native leaflets between them like a   simulation was performed alternately in each subset of five
            paper clip. To ensure maximum fixation of the THV, it is   consecutive patients (two cases assigned to the 3DP group
            critical to place the U-shaped keys accurately and expand   and three cases to the non-3DP group) per center. Thus, the
            them fully to achieve THV coaxiality, thereby reducing the   remaining 612 patients were assigned to the non-3DP group
            incidence of PVL and other procedural complications. 7,8  (n = 384) or the 3DP group (n = 228) (Figure 1). This study
                                                               conformed to the Declaration of Helsinki and was approved
              Conventionally, computed tomography angiography   by the Ethics Committee of Xijing Hospital (approval
            (CTA) has provided essential information for sizing THVs   number: KY-20192138-C-1). All patients provided written
            in patients with AR, as it does for those with AS. However,   informed consent for TAVR and follow-up data collection.
            the size and orientation of the cusps vary among individuals,
            impacting how well the U-shaped keys fit into the cusps. In   2.2. Pre-operative imaging assessment
            addition, CTA may be limited in accurately displaying THV   All patients were required to complete an electrocardiograph-
            orientation after implantation.  To address this, we used   gated coronary CTA before undergoing the procedure.
                                    9,10
            three-dimensional printing (3DP) to simulate the insertion   The standard Digital Imaging and Communications in
            of U-shaped keys into the sinuses and to optimize cusp   Medicine format for CTA data was imported into 3Mensio
            fitting, thereby maximizing clamping force.
                                                               software (Materialise, Belgium) to assess the aortic root,
              At present, no clinical studies have assessed the impact   including the annulus and the left ventricular outflow
            of coaxiality in transapical TAVR for patients with pure   tract, with particular attention to the size, location, and
            AR. Therefore, the goal of this study was to evaluate the   position of the sinuses of Valsalva and the angle of the
            feasibility of using 3DP to adjust the coaxiality of the   aorta. Horizocardia is defined as an angle >48° between the
            J-Valve before TAVR, to improve implantation accuracy   long diameter of the heart and the longitudinal diameter
            and clinical efficacy.                             of the chest.  Transthoracic echocardiography mainly
                                                                          11

            Volume 11 Issue 4 (2025)                        52                            doi: 10.36922/jctr.24.00084
   53   54   55   56   57   58   59   60   61   62   63